Big Cypress Acquisition Corp. (BCYP) Research

Big Cypress Acquisition Corp. (BCYP) aims to acquire businesses and assets. This is accomplished through various strategies, including mergers, stock purchases, capital stock exchanges, reorganizations, or comparable business integrations. The company specifically targets life science enterprises situated within the United States and Israel. It was established in 2020 and operates from its headquarters in Miami Beach, Florida.

Market snapshot

Symbol
BCYP
Price
$8.44
Day change
-19.23%
Market cap
$425.4M
P/E ratio
-1134.54x
52-week range
8.23-12.8985
Sector
Healthcare
Industry
Biotechnology

Peer companies

  • Checkpoint Therapeutics, Inc. (CKPT)
  • Climb Bio, Inc. (CLYM)
  • G1 Therapeutics, Inc. (GTHX)
  • iTeos Therapeutics, Inc. (ITOS)
  • Invivyd, Inc. (IVVD)
  • Orchard Therapeutics plc (ORTX)
  • Revance Therapeutics, Inc. (RVNC)
  • Sinovac Biotech Ltd. (SVA)

Recent insider activity

  • Martin James Joseph — trade (0 shares) on 2021-01-11
  • MERRIMAN D JONATHAN — A-Award (100000 shares) on 2016-12-27
  • MERRIMAN D JONATHAN — A-Award (1000000 shares) on 2015-04-10
  • MERRIMAN D JONATHAN — A-Award (375000 shares) on 2014-12-18
  • MERRIMAN D JONATHAN — trade (0 shares) on 2014-12-18

Open Big Cypress Acquisition Corp. (BCYP) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.